Robert Rubin

RECENT NEWS
Forbes  8 hrs ago  Comment 
Today at the Brand Innovators’ Future of Television conference in New York, social media expert Ted Rubin will be sharing his perspective on the symbiotic relationship between TV and social media. In advance of his remarks I had a conversation...
DailyFinance  Apr 23  Comment 
ALEXANDRIA, VA -- (Marketwired) -- 04/23/14 -- The American Diabetes Association will present the Richard R. Rubin Award to William H. Polonsky, PhD, CDE. This award recognizes a behavioral researcher who has made outstanding and/or innovative...
TechCrunch  Apr 22  Comment 
 If you want to find someone at a big event, it’s difficult. “I’m by the big orange thing sort of next to the pretzel vendor kinda” is pretty standard fare for communicating your whereabouts. A new Kickstarter project (via Ross Rubin on...
New York Times  Apr 21  Comment 
Also on the Minute, a tribute to the boxing champion Rubin (Hurricane) Carter and the story of a modern-day Romeo and Juliet from Afghanistan.
New York Times  Apr 21  Comment 
Rubin Carter led a fascinating life, one that can be used as a lesson to young athletes so consumed with attaining wealth and glory that they lose sight of forging an enduring legacy.
New York Times  Apr 20  Comment 
Mr. Carter, a ferocious, crowd-pleasing prizefighter, became an international cause célèbre after being convicted in New Jersey of murder and imprisoned for 19 years before the charges were dismissed.
TechCrunch  Apr 20  Comment 
Editor’s note: Ross Rubin is principal analyst at Reticle Research, a technology, media and telecom advisory firm, and founder of Backerjack. He blogs at Techspressive. Each week, Backerjack shares three tech-related products seeking funding. ...
MarketWatch  Apr 16  Comment 
Prostate cancer progresses so slowly in most cases that more men die with the disease than of it, research shows. But once a tumor is detected, how should you choose between a surgical approach and ‘watchful waiting’?’
CNNMoney.com  Apr 10  Comment 
Read full story for latest details.
Benzinga  Mar 19  Comment 
Goldman Sachs on Wednesday upgraded shares of Teva Pharmaceutical Industries (NYSE: TEVA) from Sell to Neutral and raised the price target from $40 to $52. Analyst Jami Rubin expects the “narrative around TEVA to change from concerns around a...




 

Robert Rubin is a director at Citigroup and co-chairman of the board of directors of the Council on Foreign Relations. He also served as the 70th United States Secretary of the Treasury under President Clinton and as Co-Chief Operating Officer of Goldman Sachs from 1987 to 1990. He received an LLB from Yale Law School in 1964 and a B.A. in economics from Harvard College in 1960.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki